Of cells and men: Ex vivo and in vivo tolerance to lipopolysaccharide

Critical Care Medicine

Volumn 39, Issue 8, 2011, Pages 1997-1998

  Møller, Kirsten ^a,b,c  

^a BISPEBJERG HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c Mental Health Services CPH   (Denmark)

Author keywords

cytokines; human; inflammation; Lipopolysaccharide; sepsis; tolerance

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; FLAGELLIN; INTERLEUKIN 1; INTERLEUKIN 1 ASSOCIATED KINASE M; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; LIPOTEICHOIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

BACTERIUM CONTAMINATION; BLOOD SAMPLING; BURKHOLDERIA PSEUDOMALLEI; CATHETER; CYTOKINE RESPONSE; DRUG TOLERANCE; EDITORIAL; EX VIVO STUDY; GRAM NEGATIVE SEPSIS; HUMAN; IMMOBILIZATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; SEDATION; SEPSIS; SHIGELLA DYSENTERIAE; UPREGULATION;

EID: 79961045179     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3182249931     Document Type: Editorial

References (14)

1. O'Brien JM Jr, Abraham E: Human models of endotoxemia and recombinant human activated protein C. Crit Care Med 2004; 32: S202-S208
2. Andreasen AS, Krabbe KS, Krogh-Madsen R, et al: Human endotoxemia as a model of systemic inflammation. Curr Med Chem 2008; 15:1697-1705
3. Michie HR, Manogue KR, Spriggs DR, et al: Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318:1481-1486
4. Favorite GO, Morgan HR: Eeffects produced by the intravenous injection in man of a toxic antigenic material derived from Eberthella typhosa: Clinical, hematological, chemical and serological studies. J Clin Invest 1942; 21:589-599
5. van't Veer C, van den Pangaart PS, van Zoelen MA, et al: Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J Immunol 2007; 179:7110-7120
6. Kobayashi K, Hernandez LD, Galan JE, et al: IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002; 110:191-202 (Pubitemid 34876547)
7. de Vos AF, Pater JM, van den Pangaart PS, et al: In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands. J Immunol 2009; 183:533-542
8. Kox M, de Kleijn S, Pompe JC, et al: Differential ex vivo and in vivo endotoxin tolerance kinetics following human endotoxemia. Crit Care Med 2011; 39:1866-1870
9. McNicol FJ, Hoyland JA, Cooper RG, et al: Skeletal muscle contractile properties and proinflammatory cytokine gene expression in human endotoxaemia. Br J Surg 2010; 97: 434-442
10. Frost RA, Nystrom GJ, Lang CH: Lipopolysaccharide regulates proinflammatory cytokine expression in mouse myoblasts and skeletal muscle. Am J Physiol Regul Integr Comp Physiol 2002; 283:R698-R709 (Pubitemid 34951624)
11. Jirik FR, Podor TJ, Hirano T, et al: Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol 1989; 142:144-147 (Pubitemid 19034734)
12. Erikstrup C, Ullum H, Pedersen BK: Shortterm simvastatin treatment has no effect on plasma cytokine response in a human in vivo model of low-grade inflammation. Clin Exp Immunol 2006; 144:94-100
13. Wiersinga WJ, van't Veer C, van den Pangaart PS, et al: Immunosuppression associated with interleukin-1R-associated-kinase-M upregulation predicts mortality in Gramnegative sepsis (melioidosis). Crit Care Med 2009; 37:569-576
14. Seki M, Kohno S, Newstead MW, et al: Critical role of IL-1 receptor-associated kinase-M in regulating chemokine-dependent deleterious inflammation in murine influenza pneumonia. J Immunol 2010; 184:1410-1418